New Transcriptomic Signature Predicts Prostate Cancer Progression and Identifies SLC6A8 as a Therapeutic Target
Researchers have developed a peripheral blood mRNA prognostic model that predicts the progression to metastatic castration-resistant prostate cancer, identifying SLC6A8 as a critical glycolysis-promoting biomarker that drives tumor proliferation and ... Read More